Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Non-Current Assets (2016 - 2026)

Nutex Health (NUTX) has disclosed Non-Current Assets for 17 consecutive years, with $377.7 million as the latest value for Q1 2026.

  • For Q1 2026, Non-Current Assets rose 4.79% year-over-year to $377.7 million; the TTM value through Mar 2026 reached $1.5 billion, up 10.87%, while the annual FY2025 figure was $379.7 million, 4.65% up from the prior year.
  • Non-Current Assets hit $377.7 million in Q1 2026 for Nutex Health, down from $379.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $722.8 million in Q2 2022 and bottomed at $68.4 million in Q1 2022.
  • Average Non-Current Assets over 5 years is $352.0 million, with a median of $344.2 million recorded in 2023.
  • Year-over-year, Non-Current Assets skyrocketed 907.15% in 2022 and then plummeted 52.39% in 2023.
  • Nutex Health's Non-Current Assets stood at $333.8 million in 2022, then dropped by 7.9% to $307.4 million in 2023, then rose by 18.04% to $362.8 million in 2024, then grew by 4.65% to $379.7 million in 2025, then dropped by 0.54% to $377.7 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $377.7 million, $379.7 million, and $371.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.